AN2 Therapeutics, Inc. (ANTX)

USD 1.28

(-8.57%)

Total Liabilities Summary of AN2 Therapeutics, Inc.

  • AN2 Therapeutics, Inc.'s latest annual total liabilities in 2023 was 14.04 Million USD , up 95.37% from previous year.
  • AN2 Therapeutics, Inc.'s latest quarterly total liabilities in 2024 Q2 was 10.12 Million USD , down -5.03% from previous quarter.
  • AN2 Therapeutics, Inc. reported annual total liabilities of 7.18 Million USD in 2022, down -93.62% from previous year.
  • AN2 Therapeutics, Inc. reported annual total liabilities of 112.72 Million USD in 2021, up 359.12% from previous year.
  • AN2 Therapeutics, Inc. reported quarterly total liabilities of 10.66 Million USD for 2024 Q1, down -24.07% from previous quarter.
  • AN2 Therapeutics, Inc. reported quarterly total liabilities of 14.04 Million USD for 2023 Q4, down -5.36% from previous quarter.

Annual Total Liabilities Chart of AN2 Therapeutics, Inc. (2023 - 2019)

Historical Annual Total Liabilities of AN2 Therapeutics, Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 14.04 Million USD 95.37%
2022 7.18 Million USD -93.62%
2021 112.72 Million USD 359.12%
2020 24.55 Million USD 2668.09%
2019 887 Thousand USD 0.0%

Peer Total Liabilities Comparison of AN2 Therapeutics, Inc.

Name Total Liabilities Total Liabilities Difference
AbCellera Biologics Inc. 335.77 Million USD 95.818%
Alkermes plc 933.53 Million USD 98.496%
Agenus Inc. 462.29 Million USD 96.962%
Alnylam Pharmaceuticals, Inc. 4.05 Billion USD 99.653%
Aptorum Group Limited 5.25 Million USD -167.143%
Ardelyx, Inc. 130.76 Million USD 89.261%
Arrowhead Pharmaceuticals, Inc. 478.39 Million USD 97.065%
Bicycle Therapeutics plc 224.41 Million USD 93.742%
BioXcel Therapeutics, Inc. 130.21 Million USD 89.215%
ChromaDex Corporation 26.5 Million USD 47.024%
Chimerix, Inc. 19.74 Million USD 28.878%
Corbus Pharmaceuticals Holdings, Inc. 35.17 Million USD 60.079%
Caribou Biosciences, Inc. 72.56 Million USD 80.648%
CRISPR Therapeutics AG 346.76 Million USD 95.95%
Precision BioSciences, Inc. 140.92 Million USD 90.035%
Dyadic International, Inc. 2.34 Million USD -499.961%
Eton Pharmaceuticals, Inc. 16.26 Million USD 13.651%
Fortress Biotech, Inc. 165.93 Million USD 91.537%
Lantern Pharma Inc. 2.73 Million USD -412.578%
HOOKIPA Pharma Inc. 71.48 Million USD 80.354%
Inhibikase Therapeutics, Inc. 3.52 Million USD -297.962%
Incyte Corporation 1.59 Billion USD 99.118%
IO Biotech, Inc. 17.55 Million USD 20.01%
Jaguar Health, Inc. 45.86 Million USD 69.383%
Novavax, Inc. 2.57 Billion USD 99.454%
Janux Therapeutics, Inc. 36.05 Million USD 61.054%
Opthea Limited 264.6 Million USD 94.693%
Ligand Pharmaceuticals Incorporated 130.7 Million USD 89.256%
ContextLogic Inc. 206 Million USD 93.183%
MiMedx Group, Inc. 96.33 Million USD 85.422%
Pyxis Oncology, Inc. 48.02 Million USD 70.757%
TransCode Therapeutics, Inc. 3.52 Million USD -297.944%
NextCure, Inc. 14.99 Million USD 6.361%
Ocuphire Pharma, Inc. 4.04 Million USD -247.427%
Oncternal Therapeutics, Inc. 6.67 Million USD -110.319%
Outlook Therapeutics, Inc. 46.73 Million USD 69.954%
Vaxcyte, Inc. 167.44 Million USD 91.614%
PDS Biotechnology Corporation 33.25 Million USD 57.777%
Madrigal Pharmaceuticals, Inc. 235.21 Million USD 94.03%
Pharming Group N.V. 244.07 Million USD 94.246%
Pieris Pharmaceuticals, Inc. 11.92 Million USD -17.791%
Avidity Biosciences, Inc. 127.79 Million USD 89.011%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -112.538%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -112.538%
Sangamo Therapeutics, Inc. 82.43 Million USD 82.964%
Sol-Gel Technologies Ltd. 6.64 Million USD -111.395%
Acelyrin, Inc. 86.35 Million USD 83.738%
Salarius Pharmaceuticals, Inc. 1.29 Million USD -980.862%
SELLAS Life Sciences Group, Inc. 14.37 Million USD 2.337%
Summit Therapeutics Inc. 125.25 Million USD 88.789%
Sensei Biotherapeutics, Inc. 9.47 Million USD -48.149%
Senti Biosciences, Inc. 52.57 Million USD 73.288%
Stoke Therapeutics, Inc. 68.77 Million USD 79.582%
Syros Pharmaceuticals, Inc. 151.51 Million USD 90.731%
Alaunos Therapeutics, Inc. 1.95 Million USD -617.945%
Telomir Pharmaceuticals, Inc. Common Stock 1.33 Million USD -951.466%
Entrada Therapeutics, Inc. 226.83 Million USD 93.809%
VistaGen Therapeutics, Inc. 9.36 Million USD -49.92%
Wave Life Sciences Ltd. 227.44 Million USD 93.826%
Sorrento Therapeutics, Inc. 494.5 Million USD 97.16%
TRACON Pharmaceuticals, Inc. 10.91 Million USD -28.67%
Barinthus Biotherapeutics plc 27.51 Million USD 48.955%
Psyence Biomedical Ltd. 12.1 Million USD -16.013%
Phathom Pharmaceuticals, Inc. 486.6 Million USD 97.114%
Immix Biopharma, Inc. 3.72 Million USD -277.319%
Keros Therapeutics, Inc. 37.81 Million USD 62.861%
MEI Pharma, Inc. 8.35 Million USD -68.079%
Windtree Therapeutics, Inc. 29.01 Million USD 51.601%
Xeris Biopharma Holdings, Inc. 347.58 Million USD 95.96%
Rigel Pharmaceuticals, Inc. 145.86 Million USD 90.373%
Fortress Biotech, Inc. 165.93 Million USD 91.537%
Precigen, Inc. 41.64 Million USD 66.278%
Clearside Biomedical, Inc. 49.93 Million USD 71.875%
AlloVir, Inc. 45.01 Million USD 68.804%
C4 Therapeutics, Inc. 130.33 Million USD 89.226%
Fate Therapeutics, Inc. 137.8 Million USD 89.809%
ImmuCell Corporation 18.81 Million USD 25.363%
IDEAYA Biosciences, Inc. 28.22 Million USD 50.248%
Onconetix, Inc. 23.18 Million USD 39.42%
PureTech Health plc 125.58 Million USD 88.818%
VYNE Therapeutics Inc. 8.95 Million USD -56.905%
Elevation Oncology, Inc. 34.28 Million USD 59.037%
Kintara Therapeutics, Inc. 2.44 Million USD -474.356%
Seer, Inc. 39.36 Million USD 64.326%
Verrica Pharmaceuticals Inc. 61.83 Million USD 77.289%
Innoviva, Inc. 568.55 Million USD 97.53%
Aadi Bioscience, Inc. 27.22 Million USD 48.424%
ESSA Pharma Inc. 3.49 Million USD -301.794%
GlycoMimetics, Inc. 6.9 Million USD -103.461%
GT Biopharma, Inc. 6.63 Million USD -111.714%
Inhibrx Biosciences, Inc. 264.39 Million USD 94.689%
Akebia Therapeutics, Inc. 272.28 Million USD 94.843%
Catalyst Pharmaceuticals, Inc. 84.02 Million USD 83.287%
Longboard Pharmaceuticals, Inc. 9.77 Million USD -43.677%
Orchestra BioMed Holdings, Inc. 27.16 Million USD 48.312%
Alzamend Neuro, Inc. 3.22 Million USD -335.338%
Rocket Pharmaceuticals, Inc. 73.76 Million USD 80.963%
Aptose Biosciences Inc. 15.8 Million USD 11.169%
ZyVersa Therapeutics, Inc. 11.03 Million USD -27.205%
Soligenix, Inc. 7.27 Million USD -93.033%
Century Therapeutics, Inc. 175.94 Million USD 92.018%
Kura Oncology, Inc. 51.66 Million USD 72.818%
TScan Therapeutics, Inc. 121.28 Million USD 88.421%
Intensity Therapeutics, Inc. 4.13 Million USD -239.777%
Ocean Biomedical, Inc. 6.61 Million USD -112.327%
CytomX Therapeutics, Inc. 252.59 Million USD 94.441%
Autolus Therapeutics plc 263.9 Million USD 94.679%
Mineralys Therapeutics, Inc. 10.48 Million USD -33.973%
EyePoint Pharmaceuticals, Inc. 88.86 Million USD 84.197%
Eterna Therapeutics Inc. 46.89 Million USD 70.057%
Adaptive Biotechnologies Corporation 352.85 Million USD 96.02%
GRI Bio, Inc. 2.69 Million USD -420.69%
Xenetic Biosciences, Inc. 809.58 Thousand USD -1634.592%
Tenaya Therapeutics, Inc. 31.09 Million USD 54.833%
IGM Biosciences, Inc. 220.17 Million USD 93.622%
INmune Bio, Inc. 18.86 Million USD 25.549%
Heron Therapeutics, Inc. 256.47 Million USD 94.525%
SAB Biotherapeutics, Inc. 26.64 Million USD 47.29%
Pasithea Therapeutics Corp. 2.71 Million USD -416.59%
Entero Therapeutics, Inc. 3.28 Million USD -328.106%
Milestone Pharmaceuticals Inc. 58.45 Million USD 75.976%
X4 Pharmaceuticals, Inc. 96.15 Million USD 85.396%
Atara Biotherapeutics, Inc. 264.73 Million USD 94.695%
Coherus BioSciences, Inc. 823.02 Million USD 98.294%
Verastem, Inc. 71.18 Million USD 80.273%
Abeona Therapeutics Inc. 49.17 Million USD 71.443%
Pliant Therapeutics, Inc. 38.57 Million USD 63.598%
Tonix Pharmaceuticals Holding Corp. 48.93 Million USD 71.301%
Histogen Inc. 5.69 Million USD -146.498%
Aprea Therapeutics, Inc. 4.38 Million USD -220.207%
Surrozen, Inc. 8.14 Million USD -72.413%
Organovo Holdings, Inc. 2.74 Million USD -411.026%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -4374.316%
Ovid Therapeutics Inc. 56.22 Million USD 75.026%
Panbela Therapeutics, Inc. 16.51 Million USD 14.953%
CASI Pharmaceuticals, Inc. 51.1 Million USD 72.52%
Cadrenal Therapeutics, Inc. Common Stock 826.87 Thousand USD -1598.322%
Centessa Pharmaceuticals plc 126.72 Million USD 88.919%
Hepion Pharmaceuticals, Inc. 10.81 Million USD -29.864%
Arcturus Therapeutics Holdings Inc. 150.88 Million USD 90.693%
BioRestorative Therapies, Inc. 2.6 Million USD -438.594%
Apollomics, Inc. 14.15 Million USD 0.777%
Amarin Corporation plc 279.58 Million USD 94.977%
Mesoblast Limited 188.79 Million USD 92.562%
Turnstone Biologics Corp. 14.14 Million USD 0.742%
Kymera Therapeutics, Inc. 180.78 Million USD 92.232%
Synaptogenix, Inc. 5.52 Million USD -153.967%
Tiziana Life Sciences Ltd 6.64 Million USD -111.236%
Aurinia Pharmaceuticals Inc. 170.1 Million USD 91.745%
BriaCell Therapeutics Corp. 8.55 Million USD -64.108%
Monopar Therapeutics Inc. 1.75 Million USD -699.081%
Exelixis, Inc. 678.44 Million USD 97.93%
Better Therapeutics, Inc. 23.84 Million USD 41.1%
Nurix Therapeutics, Inc. 164.04 Million USD 91.44%
Apellis Pharmaceuticals, Inc. 594.2 Million USD 97.637%
NLS Pharmaceutics AG 10.68 Million USD -31.486%
Dermata Therapeutics, Inc. 1.62 Million USD -764.921%
Aridis Pharmaceuticals, Inc. 38.92 Million USD 63.925%
Gritstone bio, Inc. 125.91 Million USD 88.848%
Jasper Therapeutics, Inc. 14.67 Million USD 4.313%
TNF Pharmaceuticals, Inc. 5.08 Million USD -175.968%
Avid Bioservices, Inc. 275.66 Million USD 94.906%
Insmed Incorporated 1.66 Billion USD 99.155%
Virpax Pharmaceuticals, Inc. 7.69 Million USD -82.518%
MediWound Ltd. 27.18 Million USD 48.347%
OmniAb, Inc. 87.4 Million USD 83.932%
Alector, Inc. 487.66 Million USD 97.12%
Seres Therapeutics, Inc. 403.45 Million USD 96.519%
Checkpoint Therapeutics, Inc. 18.42 Million USD 23.783%
Viracta Therapeutics, Inc. 38.37 Million USD 63.404%
Zai Lab Limited 240.17 Million USD 94.153%
Revance Therapeutics, Inc. 630.05 Million USD 97.771%
Aura Biosciences, Inc. 29.22 Million USD 51.952%
Lyell Immunopharma, Inc. 95.07 Million USD 85.23%
Immunic, Inc. 25.36 Million USD 44.643%
Tarsus Pharmaceuticals, Inc. 69.23 Million USD 79.717%
Veracyte, Inc. 93.71 Million USD 85.016%
InMed Pharmaceuticals Inc. 2.61 Million USD -436.674%
FibroGen, Inc. 585.72 Million USD 97.602%
SeaStar Medical Holding Corporation 17.38 Million USD 19.214%
Adial Pharmaceuticals, Inc. 653.07 Thousand USD -2050.286%
Sonnet BioTherapeutics Holdings, Inc. 5.65 Million USD -148.309%
Jazz Pharmaceuticals plc 7.65 Billion USD 99.817%
Cyclacel Pharmaceuticals, Inc. 8.19 Million USD -71.298%
Amylyx Pharmaceuticals, Inc. 84.02 Million USD 83.287%
TG Therapeutics, Inc. 169.08 Million USD 91.695%
Galecto, Inc. 5.89 Million USD -138.178%
Calithera Biosciences, Inc. 8.28 Million USD -69.52%
Fortrea Holdings Inc. 2.61 Billion USD 99.464%
KalVista Pharmaceuticals, Inc. 28.82 Million USD 51.277%
Aptevo Therapeutics Inc. 12.62 Million USD -11.267%
XBiotech Inc. 8.39 Million USD -67.238%
Jasper Therapeutics, Inc. 14.67 Million USD 4.313%
Lyra Therapeutics, Inc. 53.18 Million USD 73.593%
Foghorn Therapeutics Inc. 363.1 Million USD 96.133%
Y-mAbs Therapeutics, Inc. 26.88 Million USD 47.764%
Theravance Biopharma, Inc. 169 Million USD 91.691%
Ultragenyx Pharmaceutical Inc. 1.21 Billion USD 98.845%
Metagenomi, Inc. Common Stock 500.42 Million USD 97.194%
Vaxxinity, Inc. 30.94 Million USD 54.618%
BioCryst Pharmaceuticals, Inc. 972.48 Million USD 98.556%
Gain Therapeutics, Inc. 6.03 Million USD -132.843%
Cartesian Therapeutics, Inc. 745.23 Million USD 98.116%
NexImmune, Inc. 5.08 Million USD -176.207%
Creative Medical Technology Holdings, Inc. 371.39 Thousand USD -3681.16%
Marker Therapeutics, Inc. 3.07 Million USD -356.706%
Regeneron Pharmaceuticals, Inc. 7.1 Billion USD 99.802%
Chemomab Therapeutics Ltd. 5.15 Million USD -172.466%
Scopus BioPharma Inc. 7.45 Million USD -88.385%
RAPT Therapeutics, Inc. 26.29 Million USD 46.592%
Ainos, Inc. 7.39 Million USD -89.919%
Pluri Inc. 34.11 Million USD 58.833%
Prothena Corporation plc 135.01 Million USD 89.599%
Adaptimmune Therapeutics plc 243.1 Million USD 94.223%
Celularity Inc. 102.92 Million USD 86.357%
Rallybio Corporation 9.43 Million USD -48.824%
Cue Biopharma, Inc. 24.44 Million USD 42.553%
MeiraGTx Holdings plc 319.99 Million USD 95.611%
Omeros Corporation 403.25 Million USD 96.518%
Humacyte, Inc. 114.67 Million USD 87.754%
Immunocore Holdings plc 228.15 Million USD 93.845%
Cocrystal Pharma, Inc. 4.87 Million USD -188.062%
Cidara Therapeutics, Inc. 76.74 Million USD 81.701%
Blueprint Medicines Corporation 918.64 Million USD 98.471%
CalciMedica, Inc. 4.02 Million USD -248.635%
Cabaletta Bio, Inc. 17.45 Million USD 19.534%
Marinus Pharmaceuticals, Inc. 154.14 Million USD 90.89%
Scholar Rock Holding Corporation 85.81 Million USD 83.636%
Sana Biotechnology, Inc. 277.79 Million USD 94.945%
Pulmatrix, Inc. 15.96 Million USD 12.028%
Elicio Therapeutics, Inc. 15.77 Million USD 10.968%
Vigil Neuroscience, Inc. 24.6 Million USD 42.929%
Intellia Therapeutics, Inc. 250.8 Million USD 94.401%
Adlai Nortye Ltd. American Depositary Shares 50.78 Million USD 72.349%
Cytokinetics, Incorporated 1.21 Billion USD 98.84%
Eloxx Pharmaceuticals, Inc. 31.78 Million USD 55.816%
Nutriband Inc. 1.07 Million USD -1201.581%
Protara Therapeutics, Inc. 10.63 Million USD -32.07%
Vor Biopharma Inc. 59.1 Million USD 76.24%
Roivant Sciences Ltd. 773.95 Million USD 98.186%
Evogene Ltd. 17.99 Million USD 21.94%
ProKidney Corp. 29.21 Million USD 51.934%
Applied Therapeutics, Inc. 71.97 Million USD 80.49%
Hoth Therapeutics, Inc. 704.98 Thousand USD -1891.963%
BridgeBio Pharma, Inc. 1.88 Billion USD 99.257%
CorMedix Inc. 11.91 Million USD -17.835%
BioLineRx Ltd. 50.7 Million USD 72.303%
Tango Therapeutics, Inc. 149.45 Million USD 90.604%
Galectin Therapeutics Inc. 88.44 Million USD 84.122%
Atai Life Sciences N.V. 49.16 Million USD 71.435%
Renovaro Biosciences Inc. 31.15 Million USD 54.921%
Aerovate Therapeutics, Inc. 17.96 Million USD 21.818%
Zentalis Pharmaceuticals, Inc. 124.63 Million USD 88.733%
Sagimet Biosciences Inc. 5.65 Million USD -148.373%
MediciNova, Inc. 3.89 Million USD -260.859%
Praxis Precision Medicines, Inc. 18.27 Million USD 23.174%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -833.561%
GeoVax Labs, Inc. 3.51 Million USD -298.962%
Axsome Therapeutics, Inc. 397.25 Million USD 96.465%
Biomea Fusion, Inc. 30.69 Million USD 54.242%
PTC Therapeutics, Inc. 2.72 Billion USD 99.484%
Mereo BioPharma Group plc 15.96 Million USD 12.022%
Cullinan Oncology, Inc. 31.2 Million USD 54.992%
Syndax Pharmaceuticals, Inc. 58.68 Million USD 76.07%
Absci Corporation 58.3 Million USD 75.914%
NRx Pharmaceuticals, Inc. 19.04 Million USD 26.276%
4D Molecular Therapeutics, Inc. 32.06 Million USD 56.2%
Dyne Therapeutics, Inc. 73.79 Million USD 80.969%
Kiniksa Pharmaceuticals, Ltd. 87.48 Million USD 83.948%
Ventyx Biosciences, Inc. 33.77 Million USD 58.416%
Allakos Inc. 74.79 Million USD 81.224%
Imunon, Inc. 8.53 Million USD -64.622%
Fulcrum Therapeutics, Inc. 22.5 Million USD 37.589%
Corcept Therapeutics Incorporated 114.81 Million USD 87.769%
BioAtla, Inc. 48.98 Million USD 71.333%
NLS Pharmaceutics AG 10.68 Million USD -31.486%
Bio-Path Holdings, Inc. 2.77 Million USD -405.326%
Allogene Therapeutics, Inc. 130.6 Million USD 89.248%
Larimar Therapeutics, Inc. 14.21 Million USD 1.21%
XOMA Corporation 145.58 Million USD 90.354%
Kezar Life Sciences, Inc. 33.66 Million USD 58.286%
Cara Therapeutics, Inc. 68.75 Million USD 79.576%
aTyr Pharma, Inc. 31.59 Million USD 55.556%
Aligos Therapeutics, Inc. 61.82 Million USD 77.285%
Akero Therapeutics, Inc. 44.96 Million USD 68.769%
Viridian Therapeutics, Inc. 48.4 Million USD 70.987%
Eliem Therapeutics, Inc. 2.87 Million USD -389.303%
EyeGate Pharmaceuticals, Inc. 8.15 Million USD -72.137%
Akari Therapeutics, Plc 4.58 Million USD -206.348%
Tevogen Bio Holdings Inc. 17.73 Million USD 20.809%
Halozyme Therapeutics, Inc. 1.64 Billion USD 99.149%
Lexaria Bioscience Corp. 403.9 Thousand USD -3376.782%
UroGen Pharma Ltd. 243.52 Million USD 94.233%
Sutro Biopharma, Inc. 321.08 Million USD 95.626%
ZIVO Bioscience, Inc. 2.76 Million USD -408.517%
Orgenesis Inc. 35.53 Million USD 60.481%
Entera Bio Ltd. 1.37 Million USD -918.347%
GH Research PLC 6.7 Million USD -109.566%
Lisata Therapeutics, Inc. 6.8 Million USD -106.515%
Reneo Pharmaceuticals, Inc. 18.82 Million USD 25.406%
Xencor, Inc. 283.55 Million USD 95.048%
60 Degrees Pharmaceuticals, Inc. 2.98 Million USD -370.346%
Replimune Group, Inc. 113.21 Million USD 87.596%
Coeptis Therapeutics Holdings, Inc. 3.75 Million USD -273.77%
Vanda Pharmaceuticals Inc. 103.53 Million USD 86.436%
Lexaria Bioscience Corp. 403.9 Thousand USD -3376.782%
Portage Biotech Inc. 4.45 Million USD -215.573%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -833.561%
Olema Pharmaceuticals, Inc. 23.05 Million USD 39.076%
OncoCyte Corporation 49.29 Million USD 71.514%
Qualigen Therapeutics, Inc. 4.13 Million USD -239.465%
Processa Pharmaceuticals, Inc. 797.48 Thousand USD -1660.913%
Purple Biotech Ltd. 10 Million USD -40.36%
CollPlant Biotechnologies Ltd. 5.78 Million USD -142.707%
scPharmaceuticals Inc. 57.26 Million USD 75.475%
ProMIS Neurosciences, Inc. 12.38 Million USD -13.36%
HilleVax, Inc. 78.9 Million USD 82.204%
NeuroSense Therapeutics Ltd. 5.05 Million USD -178.079%
Tharimmune, Inc. 1.81 Million USD -673.699%
Genprex, Inc. 3.25 Million USD -331.534%
Neumora Therapeutics, Inc. Common Stock 27.11 Million USD 48.217%
Atossa Therapeutics, Inc. 5.23 Million USD -168.201%
XTL Biopharmaceuticals Ltd. 206 Thousand USD -6716.99%
Virios Therapeutics, Inc. 358.54 Thousand USD -3816.63%
OKYO Pharma Limited 7.42 Million USD -89.237%
Savara Inc. 37.19 Million USD 62.242%
Curis, Inc. 57.61 Million USD 75.625%
Daré Bioscience, Inc. 26.32 Million USD 46.665%
Carmell Therapeutics Corporation 39.19 Million USD 64.176%
Titan Pharmaceuticals, Inc. 1.44 Million USD -872.507%
Achieve Life Sciences, Inc. 20.81 Million USD 32.547%
BeiGene, Ltd. 2.23 Billion USD 99.371%
Kiromic BioPharma, Inc. 21.28 Million USD 34.039%
Revolution Medicines, Inc. Warrant 262.39 Million USD 94.648%
Protagonist Therapeutics, Inc. 21.27 Million USD 33.99%
Erasca, Inc. 78.61 Million USD 82.136%
bluebird bio, Inc. 424.62 Million USD 96.693%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -2043.145%
BioMarin Pharmaceutical Inc. 1.89 Billion USD 99.257%
DBV Technologies S.A. 42.8 Million USD 67.189%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -2043.145%
Moderna, Inc. 4.57 Billion USD 99.693%
Vincerx Pharma, Inc. 6.99 Million USD -100.758%
Fresh Tracks Therapeutics, Inc. 1.65 Million USD -748.007%
Molecular Templates, Inc. 31.17 Million USD 54.949%
Acrivon Therapeutics, Inc. Common Stock 17.07 Million USD 17.733%
Travere Therapeutics, Inc. 588.1 Million USD 97.612%
Monte Rosa Therapeutics, Inc. 124.5 Million USD 88.721%
Spruce Biosciences, Inc. 27.43 Million USD 48.817%
Celldex Therapeutics, Inc. 36.45 Million USD 61.48%
Cogent Biosciences, Inc. 55.63 Million USD 74.759%
MacroGenics, Inc. 154.2 Million USD 90.893%
RenovoRx, Inc. 4.46 Million USD -214.442%
Adicet Bio, Inc. 37.12 Million USD 62.169%
Prime Medicine, Inc. 60.78 Million USD 76.895%
Aditxt, Inc. 28.53 Million USD 50.781%
Adagene Inc. 45.16 Million USD 68.91%
Estrella Immunopharma, Inc. 180.7 Thousand USD -7671.401%
Quantum-Si incorporated 26.63 Million USD 47.268%
Maravai LifeSciences Holdings, Inc. 697.56 Million USD 97.987%
Acurx Pharmaceuticals, Inc. 3.04 Million USD -361.571%
Voyager Therapeutics, Inc. 114.96 Million USD 87.785%
SciSparc Ltd. 1.59 Million USD -780.439%
Vericel Corporation 127.7 Million USD 89.004%
Revelation Biosciences, Inc. 5.56 Million USD -152.35%
Minerva Neurosciences, Inc. 85.35 Million USD 83.548%
Generation Bio Co. 171.63 Million USD 91.818%
Astria Therapeutics, Inc. 11.55 Million USD -21.584%
Black Diamond Therapeutics, Inc. 41.83 Million USD 66.429%
Arcutis Biotherapeutics, Inc. 252.69 Million USD 94.443%
Invivyd, Inc. 51.71 Million USD 72.844%
Relay Therapeutics, Inc. 91.97 Million USD 84.732%
Quoin Pharmaceuticals, Ltd. 6.5 Million USD -115.872%
Spero Therapeutics, Inc. 75.49 Million USD 81.399%
Artelo Biosciences, Inc. 1.02 Million USD -1275.416%
2seventy bio, Inc. 310.12 Million USD 95.472%
ADMA Biologics, Inc. 193.97 Million USD 92.76%
Clene Inc. 38.95 Million USD 63.947%
Capricor Therapeutics, Inc. 36.13 Million USD 61.135%
Boundless Bio, Inc. Common Stock 256.97 Million USD 94.535%
GeoVax Labs, Inc. 3.51 Million USD -298.962%
Recursion Pharmaceuticals, Inc. 190.26 Million USD 92.619%
Citius Pharmaceuticals, Inc. 12.17 Million USD -15.299%
Contineum Therapeutics, Inc. Class A Common Stock 198.32 Million USD 92.919%
Relmada Therapeutics, Inc. 12.19 Million USD -15.156%
Finch Therapeutics Group, Inc. 48.11 Million USD 70.811%
ALX Oncology Holdings Inc. 52.84 Million USD 73.424%
Vir Biotechnology, Inc. 369.85 Million USD 96.203%
Evaxion Biotech A/S 17.61 Million USD 20.289%
Ocular Therapeutix, Inc. 160.92 Million USD 91.274%
Verve Therapeutics, Inc. 153.18 Million USD 90.833%
Trevena, Inc. 48.26 Million USD 70.903%
Surrozen, Inc. 8.14 Million USD -72.413%
Tyra Biosciences, Inc. 21.59 Million USD 34.971%
Cingulate Inc. 10.36 Million USD -35.539%
Galmed Pharmaceuticals Ltd. 2.75 Million USD -410.655%
Unity Biotechnology, Inc. 37.29 Million USD 62.343%
Tenax Therapeutics, Inc. 3.58 Million USD -291.549%
Terns Pharmaceuticals, Inc. 13.15 Million USD -6.791%
ACADIA Pharmaceuticals Inc. 317.2 Million USD 95.573%
Connect Biopharma Holdings Limited 24.84 Million USD 43.487%
Clearmind Medicine Inc. 3.61 Million USD -289.002%
Kronos Bio, Inc. 54.2 Million USD 74.091%
Bolt Biotherapeutics, Inc. 47.04 Million USD 70.149%
CERo Therapeutics Holdings, Inc. 22.75 Million USD 38.299%
Viking Therapeutics, Inc. 20.07 Million USD 30.033%
Statera Biopharma, Inc. 22.67 Million USD 38.072%
ImmunityBio, Inc. 1.09 Billion USD 98.712%
Korro Bio, Inc. 51.75 Million USD 72.865%
Kineta, Inc. 7.22 Million USD -94.448%
BioVie Inc. 9.7 Million USD -44.741%
Codexis, Inc. 49.94 Million USD 71.884%
Celularity Inc. 102.92 Million USD 86.357%
Crinetics Pharmaceuticals, Inc. 96.24 Million USD 85.409%
Celcuity Inc. 51.45 Million USD 72.706%
Virax Biolabs Group Limited 345.19 Thousand USD -3968.147%
Cibus, Inc. 206.11 Million USD 93.187%
Eledon Pharmaceuticals, Inc. 42.47 Million USD 66.938%
eFFECTOR Therapeutics, Inc. 26.33 Million USD 46.684%
IN8bio, Inc. 8.77 Million USD -60.089%
Kodiak Sciences Inc. 213.59 Million USD 93.425%
Annexon, Inc. 47.11 Million USD 70.196%
Adverum Biotechnologies, Inc. 89.54 Million USD 84.317%
Assembly Biosciences, Inc. 96.37 Million USD 85.428%
Avalo Therapeutics, Inc. 13.68 Million USD -2.586%
Ionis Pharmaceuticals, Inc. 2.6 Billion USD 99.461%
Eyenovia, Inc. 19.78 Million USD 29.005%
Puma Biotechnology, Inc. 177.08 Million USD 92.07%
Conduit Pharmaceuticals Inc. 7.68 Million USD -82.828%
Xilio Therapeutics, Inc. 24.09 Million USD 41.728%
Arcellx, Inc. 339.75 Million USD 95.867%
Cardiff Oncology, Inc. 11.89 Million USD -18.028%
Enanta Pharmaceuticals, Inc. 245.54 Million USD 94.281%
Regulus Therapeutics Inc. 9.56 Million USD -46.847%
Moolec Science SA 13.94 Million USD -0.7%
Acumen Pharmaceuticals, Inc. 43.15 Million USD 67.457%
Geron Corporation 146.12 Million USD 90.39%
LAVA Therapeutics N.V. 50.53 Million USD 72.21%
Royalty Pharma plc 6.29 Billion USD 99.777%
Atea Pharmaceuticals, Inc. 39.77 Million USD 64.695%
Greenwich LifeSciences, Inc. 294.4 Thousand USD -4669.944%
TFF Pharmaceuticals, Inc. 2.46 Million USD -470.788%
Mersana Therapeutics, Inc. 189.15 Million USD 92.576%
Humacyte, Inc. 114.67 Million USD 87.754%
Structure Therapeutics Inc. 29.05 Million USD 51.661%
89bio, Inc. 59.96 Million USD 76.581%
PMV Pharmaceuticals, Inc. 26.46 Million USD 46.933%
Avenue Therapeutics, Inc. 1.19 Million USD -1074.164%
Genelux Corporation 8.42 Million USD -66.781%
Trevi Therapeutics, Inc. 6.85 Million USD -104.828%
Lexicon Pharmaceuticals, Inc. 136.31 Million USD 89.698%
Notable Labs, Ltd. 4.42 Million USD -217.213%
Liquidia Corporation 73.13 Million USD 80.799%
Mustang Bio, Inc. 17.61 Million USD 20.296%
Immunovant, Inc. 48.95 Million USD 71.314%
Quantum-Si incorporated 26.63 Million USD 47.268%
Arbutus Biopharma Corporation 38.38 Million USD 63.413%
DiaMedica Therapeutics Inc. 3.1 Million USD -352.562%
Vera Therapeutics, Inc. 73.86 Million USD 80.987%
Acasti Pharma Inc. 11.55 Million USD -21.511%
MiNK Therapeutics, Inc. 22.6 Million USD 37.884%
Pasithea Therapeutics Corp. 2.71 Million USD -416.59%
Xenon Pharmaceuticals Inc. 36.87 Million USD 61.919%
Elevai Labs, Inc. Common Stock 1.36 Million USD -930.42%
NeuroBo Pharmaceuticals, Inc. 6.09 Million USD -130.364%
Tempest Therapeutics, Inc. 24.83 Million USD 43.455%
Soleno Therapeutics, Inc. 23.18 Million USD 39.428%
PepGen Inc. 34.63 Million USD 59.45%
Moleculin Biotech, Inc. 12.14 Million USD -15.637%
United Therapeutics Corporation 1.18 Billion USD 98.812%
Nuvectis Pharma, Inc. 6.98 Million USD -101.074%
Solid Biosciences Inc. 38.45 Million USD 63.485%
BriaCell Therapeutics Corp. 8.55 Million USD -64.108%
Immuneering Corporation 12 Million USD -16.944%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -4374.316%
Silo Pharma, Inc. 1.56 Million USD -794.875%
Belite Bio, Inc 4.21 Million USD -233.484%
XOMA Corporation 145.58 Million USD 90.354%
ARS Pharmaceuticals, Inc. 2.42 Million USD -478.377%
Bionomics Limited 10.15 Million USD -38.236%
Apogee Therapeutics, Inc. 21.49 Million USD 34.656%
Alpha Tau Medical Ltd. 22.91 Million USD 38.712%
uniQure N.V. 624.01 Million USD 97.75%
Cassava Sciences, Inc. 14.19 Million USD 1.071%
Estrella Immunopharma, Inc. 180.7 Thousand USD -7671.401%
Poseida Therapeutics, Inc. 170.18 Million USD 91.748%
Forte Biosciences, Inc. 3.66 Million USD -283.061%
Anebulo Pharmaceuticals, Inc. 260.58 Thousand USD -5289.07%
Enlivex Therapeutics Ltd. 6.74 Million USD -108.137%
Conduit Pharmaceuticals Inc. 7.68 Million USD -82.828%
SeaStar Medical Holding Corporation 17.38 Million USD 19.214%
FibroBiologics, Inc. Common Stock 10.56 Million USD -32.882%
Altimmune, Inc. 16.54 Million USD 15.102%
Amicus Therapeutics, Inc. 617.7 Million USD 97.727%
Alpha Tau Medical Ltd. 22.91 Million USD 38.712%
Compugen Ltd. 55.77 Million USD 74.822%
Peak Bio, Inc. 20.75 Million USD 32.334%
Zevra Therapeutics, Inc. 110.46 Million USD 87.287%
Benitec Biopharma Inc. 4.96 Million USD -183.011%
Spyre Therapeutics, Inc. 157.84 Million USD 91.103%
NKGen Biotech, Inc. Common Stock 75.17 Million USD 81.319%
Zura Bio Limited 21.29 Million USD 34.046%
PolyPid Ltd. 17.46 Million USD 19.607%
Aileron Therapeutics, Inc. 112.39 Million USD 87.506%
NKGen Biotech, Inc. Warrants 75.17 Million USD 81.319%
Instil Bio, Inc. 99.8 Million USD 85.929%
argenx SE 444.95 Million USD 96.844%
Immunome, Inc. 28.65 Million USD 50.998%
Compass Therapeutics, Inc. 8.33 Million USD -68.442%
Verona Pharma plc 58.84 Million USD 76.134%
enGene Holdings Inc. Warrants 14.47 Million USD 2.971%
Shattuck Labs, Inc. 14.85 Million USD 5.492%
CervoMed Inc. 2.59 Million USD -441.0%
LENZ Therapeutics, Inc. 4.87 Million USD -188.121%
Plus Therapeutics, Inc. 12.73 Million USD -10.262%
Dianthus Therapeutics, Inc. 10.53 Million USD -33.299%
Moolec Science SA 13.94 Million USD -0.7%
Enveric Biosciences, Inc. 2.34 Million USD -499.231%
Inovio Pharmaceuticals, Inc. 55.59 Million USD 74.741%
AnaptysBio, Inc. 364.28 Million USD 96.145%
Design Therapeutics, Inc. 11.95 Million USD -17.456%
Leap Therapeutics, Inc. 12.68 Million USD -10.714%
NeurAxis, Inc. 1.91 Million USD -634.183%
Seelos Therapeutics, Inc. 38.92 Million USD 63.926%
Lumos Pharma, Inc. 13.33 Million USD -5.325%
Achilles Therapeutics plc 19.08 Million USD 26.426%
enGene Holdings Inc. Common Stock 14.47 Million USD 2.971%
180 Life Sciences Corp. 5.38 Million USD -160.673%
Opiant Pharmaceuticals, Inc. 23.58 Million USD 40.465%
CERo Therapeutics Holdings, Inc. 22.75 Million USD 38.299%
Nutriband Inc. 1.07 Million USD -1201.581%
ORIC Pharmaceuticals, Inc. 30.59 Million USD 54.105%
CG Oncology, Inc. Common stock 14.51 Million USD 3.225%
Fractyl Health, Inc. Common Stock 401.27 Million USD 96.5%
Rani Therapeutics Holdings, Inc. 32.47 Million USD 56.755%
MoonLake Immunotherapeutics 13.04 Million USD -7.617%
Palisade Bio, Inc. 2.73 Million USD -412.705%
Tourmaline Bio, Inc. 5.25 Million USD -167.333%
Beam Therapeutics Inc. 478.38 Million USD 97.064%
Neurogene Inc. 36.54 Million USD 61.578%
Mirum Pharmaceuticals, Inc. 397.95 Million USD 96.471%
AEON Biopharma, Inc. 159.88 Million USD 91.217%
CARGO Therapeutics, Inc. Common Stock 47.65 Million USD 70.529%
Sesen Bio, Inc. 30.98 Million USD 54.677%
Enliven Therapeutics, Inc. 25.96 Million USD 45.907%
Kiora Pharmaceuticals, Inc. 7.6 Million USD -84.722%
Iovance Biotherapeutics, Inc. 195.73 Million USD 92.826%
Taysha Gene Therapies, Inc. 192.05 Million USD 92.688%
Athira Pharma, Inc. 30.05 Million USD 53.279%
Vaccinex, Inc. 5.94 Million USD -136.335%
HCW Biologics Inc. 15.05 Million USD 6.703%
XOMA Corporation 145.58 Million USD 90.354%
Nektar Therapeutics 267.04 Million USD 94.741%
Arvinas, Inc. 644.6 Million USD 97.821%
Tevogen Bio Holdings Inc. 17.73 Million USD 20.809%
Merus N.V. 102.15 Million USD 86.253%
Omega Therapeutics, Inc. 146.35 Million USD 90.405%
Quince Therapeutics, Inc. 95.12 Million USD 85.237%
Rezolute, Inc. 11.73 Million USD -19.678%
Clene Inc. 38.95 Million USD 63.947%
Indaptus Therapeutics, Inc. 2.84 Million USD -393.19%
BeyondSpring Inc. 48.26 Million USD 70.907%
Synlogic, Inc. 32.89 Million USD 57.31%
Allarity Therapeutics, Inc. 14.61 Million USD 3.901%
Phio Pharmaceuticals Corp. 1.63 Million USD -759.425%
Peak Bio, Inc. 20.75 Million USD 32.334%
Werewolf Therapeutics, Inc. 63.45 Million USD 77.871%
Krystal Biotech, Inc. 39.71 Million USD 64.64%
Karyopharm Therapeutics Inc. 376.64 Million USD 96.272%
SpringWorks Therapeutics, Inc. 99.56 Million USD 85.896%
Lipella Pharmaceuticals Inc. 432.72 Thousand USD -3145.241%
MannKind Corporation 721.36 Million USD 98.053%
Ikena Oncology, Inc. 22.33 Million USD 37.126%
Cyclerion Therapeutics, Inc. 2.08 Million USD -573.202%
Gyre Therapeutics, Inc. 102.59 Million USD 86.312%
Gossamer Bio, Inc. 249.14 Million USD 94.364%
CohBar, Inc. 1.03 Million USD -1258.599%
Cognition Therapeutics, Inc. 10.68 Million USD -31.378%
NRx Pharmaceuticals, Inc. 19.04 Million USD 26.276%
Legend Biotech Corporation 589.93 Million USD 97.62%
Mural Oncology plc 37.92 Million USD 62.975%
Biora Therapeutics, Inc. 132.63 Million USD 89.412%
PaxMedica, Inc. Common Stock 2.29 Million USD -511.807%
Disc Medicine, Inc. 22.87 Million USD 38.61%
Champions Oncology, Inc. 28.03 Million USD 49.909%
REGENXBIO Inc. 262.22 Million USD 94.645%
Ensysce Biosciences, Inc. 3.35 Million USD -318.027%
Anavex Life Sciences Corp. 12.53 Million USD -12.039%
Cellectar Biosciences, Inc. 13.43 Million USD -4.552%
Edgewise Therapeutics, Inc. 21.2 Million USD 33.775%
Vaxart, Inc. 34.02 Million USD 58.727%
PharmaCyte Biotech, Inc. 20.38 Million USD 31.126%
Aldeyra Therapeutics, Inc. 28.53 Million USD 50.781%
Cellectis S.A. 249.57 Million USD 94.373%
Longeveron Inc. 5.33 Million USD -163.125%
Repare Therapeutics Inc. 41.81 Million USD 66.42%
Sarepta Therapeutics, Inc. 2.4 Billion USD 99.416%
Inozyme Pharma, Inc. 60.36 Million USD 76.738%
Revolution Medicines, Inc. 262.39 Million USD 94.648%
Nymox Pharmaceutical Corporation 2.1 Million USD -566.493%
Third Harmonic Bio, Inc. 8.62 Million USD -62.799%
ArriVent BioPharma, Inc. Common Stock 11.8 Million USD -18.998%
Anixa Biosciences, Inc. 2.15 Million USD -552.859%
Vertex Pharmaceuticals Incorporated 5.14 Billion USD 99.727%
Denali Therapeutics Inc. 122.96 Million USD 88.579%
Revelation Biosciences, Inc. 5.56 Million USD -152.35%
Veru Inc. 32.81 Million USD 57.203%
Corvus Pharmaceuticals, Inc. 6.86 Million USD -104.44%
Cingulate Inc. 10.36 Million USD -35.539%
Passage Bio, Inc. 39.26 Million USD 64.233%
Context Therapeutics Inc. 4.19 Million USD -235.018%
Exicure, Inc. 8.54 Million USD -64.265%
Day One Biopharmaceuticals, Inc. 29.5 Million USD 52.41%
Oramed Pharmaceuticals Inc. 10.48 Million USD -33.921%
Scinai Immunotherapeutics Ltd. 22.04 Million USD 36.287%
Rhythm Pharmaceuticals, Inc. 162.98 Million USD 91.384%
Nuvalent, Inc. 31.82 Million USD 55.872%
ABVC BioPharma, Inc. 6.36 Million USD -120.745%
Carisma Therapeutics, Inc. 63.02 Million USD 77.717%
Unicycive Therapeutics, Inc. 18 Million USD 21.983%
OmniAb, Inc. 87.4 Million USD 83.932%
Anew Medical, Inc. 8.24 Million USD -70.388%
Fennec Pharmaceuticals Inc. 38.28 Million USD 63.324%
Lipocine Inc. 2.63 Million USD -433.624%
Lexeo Therapeutics, Inc. Common Stock 26.27 Million USD 46.548%
Nautilus Biotechnology, Inc. 40.21 Million USD 65.078%
SAB Biotherapeutics, Inc. 26.64 Million USD 47.29%
G1 Therapeutics, Inc. 86.15 Million USD 83.7%
Bellerophon Therapeutics, Inc. 5.4 Million USD -160.007%
Sage Therapeutics, Inc. 82.74 Million USD 83.029%
Ocugen, Inc. 23.98 Million USD 41.446%
Mind Medicine (MindMed) Inc. 46.4 Million USD 69.739%
Q32 Bio Inc. 233.12 Million USD 93.976%
Brainstorm Cell Therapeutics Inc. 9.06 Million USD -54.897%
Alumis Inc. Common Stock 53.5 Million USD 73.752%
Equillium, Inc. 27.95 Million USD 49.769%
Kyverna Therapeutics, Inc. 206.59 Million USD 93.203%
Coya Therapeutics, Inc. 5.62 Million USD -149.579%
CNS Pharmaceuticals, Inc. 6.13 Million USD -128.976%
Galera Therapeutics, Inc. 157.32 Million USD 91.074%
Evelo Biosciences, Inc. 69.43 Million USD 79.775%
Comera Life Sciences Holdings, Inc. 9.97 Million USD -40.793%
Dominari Holdings Inc. 4.63 Million USD -202.977%
Edesa Biotech, Inc. 1.84 Million USD -662.528%
vTv Therapeutics Inc. 29.56 Million USD 52.504%
Bio-Techne Corporation 744.34 Million USD 98.113%
Agios Pharmaceuticals, Inc. 126.09 Million USD 88.864%
Harmony Biosciences Holdings, Inc. 344.45 Million USD 95.923%
Prelude Therapeutics Incorporated 40.57 Million USD 65.39%
Candel Therapeutics, Inc. 28.95 Million USD 51.504%
iTeos Therapeutics, Inc. 92.36 Million USD 84.795%
Nkarta, Inc. 105.6 Million USD 86.702%
BioCardia, Inc. 4.59 Million USD -205.948%
Iterum Therapeutics plc 32.66 Million USD 57.005%